Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVMED-85 in healthy adults
NCT07370584Phase 1Recruiting
- Start
- Feb 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in keratoconus comparing Vehicle ophthalmic solution with IVMED-85 ophthalmic solution (2 arms). Primary endpoints: Visual acuity at 6 weeks, Change in eye assessments at 6 weeks and 2 more. Started Feb 2026; status: recruiting.
02
Drugs
IVMED-85
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT07370584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07370584.